Home  >  Products  >  MINA (MYC induced nuclear antigen) Blocking Peptide (the N terminal of protein) (100ug)
MINA (MYC induced nuclear antigen) Blocking Peptide (the N terminal of protein) (100ug)

MINA (MYC induced nuclear antigen) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MINA antibody (Catalogue #: ARP30020_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP30020
Size: 100 ug
Weight: 53kDa
Gene: 84864
Format: Lyophilized powder
Target: MINA protein is directly involved in ribosome biogenesis, most likely during the assembly process of preribosomal particles. MINA is also involved in cell proliferation. MINA may have a role in esophageal squamous cell carcinoma, colon cancer and lung cancer.MINA is a c-Myc (MYC; MIM 190080) target gene that may play a role in cell proliferation or regulation of cell growth. (Tsuneoka et al., 2002 [PubMed 12091391]; Zhang et al., 2005 [PubMed 15897898]).[supplied by OMIM].
Alternative names: DKFZp762O1912; FLJ14393; MDIG; MINA53; NO52
See Full Product Listings >